Phase II study of paclitaxel in pretreated patients with locally advanced/metastatic cancer of the bladder and ureter

被引:91
作者
Papamichael, D
Gallagher, CJ
Oliver, RTD
Johnson, PW
Waxman, J
机构
[1] UNIV LONDON ST BARTHOLOMEWS HOSP MED COLL,DEPT MED ONCOL,LONDON EC1A 7BE,ENGLAND
[2] ST JAMES UNIV HOSP,DEPT MED ONCOL,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND
[3] HAMMERSMITH HOSP,DEPT MED ONCOL,LONDON,ENGLAND
关键词
paclitaxel; bladder cancer; transitional cell carcinoma;
D O I
10.1038/bjc.1997.106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Fourteen patients with previously treated, locally advanced/metastatic transitional cell carcinoma (TCC) of the bladder or ureter received paclitaxel at a dose of 200 mg m(-2) administered as a 3-h infusion every 21 days. The activity of paclitaxel in this group of patients was modest. The response rates were one partial response (PR) (7%) and three stable disease (SD). There were two early deaths.
引用
收藏
页码:606 / 607
页数:2
相关论文
共 11 条
[1]  
DEHAVEN J, 1995, P AM ASSOC CANC RES, V36, pA1765
[2]  
DREICER R, 1996, P AM SOC CLIN ONCOL, V15, pA607
[3]   EUROPEAN-CANADIAN RANDOMIZED TRIAL OF PACLITAXEL IN RELAPSED OVARIAN-CANCER - HIGH-DOSE VERSUS LOW-DOSE AND LONG VERSUS SHORT INFUSION [J].
EISENHAUER, EA ;
HUININK, WWT ;
SWENERTON, KD ;
GIANNI, L ;
MYLES, J ;
VANDERBURG, MEL ;
KERR, I ;
VERMORKEN, JB ;
BUSER, K ;
COLOMBO, N ;
BACON, M ;
SANTABARBARA, P ;
ONETTO, N ;
WINOGRAD, B ;
CANETTA, R .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (12) :2654-2666
[4]  
KEUNG A, 1993, P AM SOC CLIN ONCOL, V12, pA321
[5]   TAXOL - A UNIQUE ANTINEOPLASTIC AGENT WITH SIGNIFICANT ACTIVITY IN ADVANCED OVARIAN EPITHELIAL NEOPLASMS [J].
MCGUIRE, WP ;
ROWINSKY, EK ;
ROSENSHEIN, NB ;
GRUMBINE, FC ;
ETTINGER, DS ;
ARMSTRONG, DK ;
DONEHOWER, RC .
ANNALS OF INTERNAL MEDICINE, 1989, 111 (04) :273-279
[6]   PHASE-II STUDY OF TAXOL IN PATIENTS WITH UNTREATED ADVANCED NON-SMALL-CELL LUNG-CANCER [J].
MURPHY, WK ;
FOSSELLA, FV ;
WINN, RJ ;
SHIN, DM ;
HYNES, HE ;
GROSS, HM ;
DAVILLA, E ;
LEIMERT, J ;
DHINGRA, H ;
RABER, MN ;
KRAKOFF, IH ;
HONG, WK .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :384-388
[7]   TAXOL AND TAXOTERE IN BLADDER-CANCER - IN-VITRO ACTIVITY AND URINE STABILITY [J].
RANGEL, C ;
NIELL, H ;
MILLER, A ;
COX, C .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 33 (06) :460-464
[8]   SIGNIFICANT ACTIVITY OF PACLITAXEL IN ADVANCED TRANSITIONAL-CELL CARCINOMA OF THE UROTHELIUM - A PHASE-II TRIAL OF THE EASTERN-COOPERATIVE-ONCOLOGY-GROUP [J].
ROTH, BJ ;
DREICER, R ;
EINHORN, LH ;
NEUBERG, D ;
JOHNSON, DH ;
SMITH, JL ;
HUDES, GR ;
SCHULTZ, SM ;
LOEHRER, PJ .
JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (11) :2264-2270
[9]   CHEMOTHERAPY FOR UROTHELIAL TRACT MALIGNANCIES - BREAKING THE DEADLOCK [J].
SCHER, HI ;
NORTON, L .
SEMINARS IN SURGICAL ONCOLOGY, 1992, 8 (05) :316-341
[10]  
SCHILDER L, 1994, P AM SOC CLIN ONCOL, V13, pA338